Amended Statement of Beneficial Ownership (sc 13d/a)

Date : 08/20/2019 @ 10:02AM
Source : Edgar (US Regulatory)
Stock : AngioSoma Inc (PK) (SOAN)
Quote : 0.0012  0.0 (0.00%) @ 12:35PM

Amended Statement of Beneficial Ownership (sc 13d/a)


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


SCHEDULE 13D/A

Rule 13d-101

Amendment Number 1


Under the Securities Exchange Act of 1934



AngioSoma, Inc.

(Name of Issuer)



Series E Preferred Stock, par value $.001 per share

(Title of Class of Securities)



None

(CUSIP Number)



Alex K. Blankenship

2500 Wilcrest Drive, Suite 300

Houston, Texas 77042

832-781-8521

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)



May 16, 2017

(Date of Event which Requires Filing of this Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [X].


Note . Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.


The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.)




CUSIP No.    N/A


1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)


Alex K. Blankenship

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*


(a) [_]

(b) [X]

3.

SEC USE ONLY

 

4.

SOURCE OF FUNDS


N/A

5.

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2 (e)


[_]

6.

CITIZENSHIP OR PLACE OF ORGANIZATION


United States of America

NUMBER

OF

SHARES

BENEFICIALLY

OWNED

BY

EACH

REPORTING

PERSON

WITH

7. SOLE VOTING POWER


1,000,000

8. SHARED VOTING POWER


None

9. SOLE DISPOSITIVE POWER


1,000,000

10. SHARED DISPOSITIVE POWER


None

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON


1,000,000

12.

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES


[_]

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)


100%

14.

TYPE OF REPORTING PERSON


IN


- 2 -



Item 1. Security and Issuer.


This statement relates to the Series E preferred stock, par value $0.001 per share (the “Preferred Stock”), of AngioSoma, Inc., a Nevada corporation (the “Issuer”), whose principal executive office is located at 2500 Wilcrest Drive, Suite 300, Houston, Texas 77042.


Item 2. Identity and Background.


(a)

Alex K. Blankenship, a natural person (“Ms. Blankenship”).

 

 

(b)

2500 Wilcrest Drive, Suite 300, Houston, Texas 77042

 

 

(c)

Ms. Blankenship’s principal occupation is President and Chief Executive Officer of the Issuer.

 

 

(d)

During the last five years, Ms. Blankenship has not been convicted in a criminal proceeding (excluding traffic or other misdemeanors).

 

 

(e)

Ms. Blankenship has not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction which resulted in or was subject to (i) a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws; or (ii) a finding of any violation with respect to such laws.

 

 

(f)

Ms. Blankenship is a citizen of the United States.


Item 3. Source and Amount of Funds or Other Consideration.


Not applicable.


Item 4. Purpose of Transaction.


To reverse the divestiture of sole voting rights of the preferred stock previously transferred to David P. Summers.


Item 5. Interest in Securities of Issuer.


(a)

As of the date of this report, Ms. Blankenship beneficially owns 100% of shares of the Issuer’s Series E Preferred Stock.

 

 

(b)

Ms. Blankenship has the sole power to vote and has sole power to dispose or direct the disposition of the Issuer’s Series E Preferred Stock.

 

 

(c)

Beneficial ownership of 1,000,000 shares of Preferred Stock.

 

 

(d)

Ms. Blankenship confirms that she is entitled to exclusive voting rights of the Series E Preferred Stock and is the person with the exclusive right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any of the shares of Preferred Stock beneficially owned by Alex K. Blankenship.

 

 

(e)

Not applicable.


- 3 -



Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.


Pursuant to the terms of an amendment to the designation of the Series E preferred stock filed May 16, 2017 and a correction thereof filed February 14, 2018, attached hereto as Exhibit 99.1 and 99.2, Ms. Blankenship reclaimed the exclusive, irrevocable right to vote all shares of Preferred Stock beneficially owned by Ms. Blankenship.


Item 7. Materials to be Filed as Exhibits.


99.1 Amendment to Certificate of Designation Series E Preferred Stock filed with the Secretary of State of Nevada May 16, 2017.


99.2 Certificate of Correction filed with the Secretary of State of Nevada February 14, 2018.



EXHIBITS


Exhibit No.

 

Description

 

 

 

99.1

 

Amendment to Certificate of Designation Series E Preferred Stock filed with the Secretary of State of Nevada May 16, 2017.

 

 

 

99.2

 

Certificate of Correction filed with the Secretary of State of Nevada February 14, 2018.



SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.



/s/ Alex K. Blankenship

Name: Alex K. Blankenship

Date: August 19, 2019


- 4 -


AngioSoma (PK) (USOTC:SOAN)
Historical Stock Chart

1 Year : From Feb 2019 to Feb 2020

Click Here for more AngioSoma (PK) Charts.

AngioSoma (PK) (USOTC:SOAN)
Intraday Stock Chart

Today : Friday 28 February 2020

Click Here for more AngioSoma (PK) Charts.

Latest SOAN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.